Acupressure points for gynaecomastia are increasingly searched online, yet the evidence base for this approach is absent. Gynaecomastia — the benign enlargement of glandular breast tissue in males — is a common condition with a range of hormonal, medication-related, and physiological causes. While Traditional Chinese Medicine proposes that stimulating specific pressure points may influence hormonal balance, no clinical trials or UK regulatory guidance support acupressure as a treatment for gynaecomastia. This article explains what the evidence does and does not show, outlines NHS-recognised treatments, and clarifies when to seek prompt medical assessment.

What Is Gynaecomastia and What Causes It?

Gynaecomastia is benign glandular breast tissue enlargement in males, caused by an imbalance between oestrogen and androgen activity; common triggers include puberty, ageing, certain medications, and underlying medical conditions.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gynaecomastia refers to the benign enlargement of glandular breast tissue in males. It is distinct from pseudogynaecomastia, which involves fatty tissue deposition rather than true glandular growth — a distinction that is important in primary care, where obesity is a common contributor to breast enlargement. The condition can affect one or both breasts and may present with tenderness or sensitivity. It is relatively common, with prevalence varying considerably by age group and study methodology; peaks occur during infancy, puberty, and older age.

The underlying cause is typically an imbalance between oestrogen and androgen activity in breast tissue. Several factors can contribute to this hormonal shift, including:

• Physiological changes during puberty or ageing

• Medications — a wide range of commonly prescribed drugs can cause gynaecomastia, including anabolic steroids, anti-androgens (e.g., spironolactone, finasteride, dutasteride, bicalutamide), antipsychotics, some antidepressants, certain antihypertensives, cimetidine, and antiretrovirals such as efavirenz

• Medical conditions including hypogonadism (including Klinefelter syndrome), hyperthyroidism, liver cirrhosis, and chronic kidney disease

• hCG-secreting tumours of the testis or adrenal gland, which are rare but clinically important

• Recreational substances such as cannabis and alcohol

• Idiopathic causes, where no clear trigger is identified

In many adolescent males, pubertal gynaecomastia resolves spontaneously within one to two years without intervention. However, persistent or adult-onset gynaecomastia warrants clinical evaluation to exclude underlying pathology, including rare but important causes such as testicular or adrenal tumours. Understanding the root cause is essential before considering any form of management, whether conventional or complementary.

Further information: NHS — Enlarged breasts in men (gynaecomastia); NICE CKS — Gynaecomastia.

What the Evidence Says About Acupressure for Gynaecomastia

There is no clinical evidence from peer-reviewed studies or UK guidance bodies — including NICE, the NHS, or the MHRA — to support acupressure as a treatment for gynaecomastia.

Acupressure is a traditional practice rooted in Traditional Chinese Medicine (TCM), based on the concept that applying physical pressure to specific points on the body can influence the flow of energy, or 'qi', along pathways known as meridians. Some proponents suggest it may help regulate hormonal balance, reduce inflammation, and support lymphatic drainage. It is important to note that these proposed mechanisms are unproven and theoretical; they have not been validated through rigorous scientific methodology.

It is important to state clearly that there is no clinical evidence from peer-reviewed studies, systematic reviews, or regulatory and advisory bodies such as NICE, the NHS, or the MHRA to support the use of acupressure as a treatment for gynaecomastia. No randomised controlled trials have examined this specific application, and NICE CKS guidance on gynaecomastia does not include acupressure among recognised management options.

While acupressure has demonstrated modest benefits in certain other contexts — for example, NHS guidance acknowledges that acupressure wristbands may help some people with pregnancy-related nausea — these findings cannot be extrapolated to breast tissue changes in males. The absence of evidence is not the same as evidence of harm, but patients should be cautious about claims suggesting acupressure can meaningfully reduce glandular breast tissue. Such claims are not supported by current medical science, and relying solely on acupressure in place of appropriate medical assessment could delay the diagnosis of an underlying condition requiring treatment.

Commonly Referenced Acupressure Points and Their Claimed Effects

Points such as ST16, CV17, LI4, SP6, and KD3 are cited in TCM literature for hormonal or chest-related concerns, but no official medical body endorses them as a treatment for gynaecomastia.

Despite the lack of clinical evidence, various online sources and TCM practitioners reference specific acupressure points in relation to hormonal balance and chest-related concerns. The following information is provided for educational context only. No official medical body — including NICE, the NHS, or the MHRA — endorses these points as a treatment or intervention for gynaecomastia, and they should not be used as a substitute for medical assessment.

Commonly cited points include:

• ST16 (Stomach 16) — Located on the chest, this point is claimed to support breast tissue health and improve local circulation. In TCM theory, it is associated with the stomach meridian.

• CV17 (Conception Vessel 17) — Situated at the centre of the sternum, this point is said to regulate qi in the chest area and is sometimes linked to emotional and hormonal balance.

• LI4 (Large Intestine 4) — Found in the webbing between the thumb and index finger, this is one of the most widely used acupressure points, claimed to reduce inflammation and support general wellbeing.

• SP6 (Spleen 6) — Located above the ankle on the inner leg, this point is frequently cited in TCM for hormonal regulation, particularly in relation to reproductive health.

• KD3 (Kidney 3) — Positioned near the inner ankle, it is associated in TCM with kidney energy, which practitioners link to hormonal and endocrine function.

These points are described in TCM literature as influencing energy flow rather than directly altering hormone levels in any measurable physiological sense. Patients should approach such claims with appropriate scepticism.

Safety cautions: Do not apply pressure directly over a new or undiagnosed breast lump, broken or infected skin, or any area that has recently undergone surgery. Individuals with bleeding disorders or those taking anticoagulant medicines should seek medical advice before using acupressure. Stop immediately if you experience pain, bruising, or worsening symptoms, and seek medical advice. If you notice any new changes in breast tissue during or after self-administered acupressure, do not delay seeking a GP assessment.

NHS-Recognised Treatments for Gynaecomastia

NHS-recognised options include watchful waiting, addressing underlying causes, off-label medicines such as tamoxifen (specialist-initiated), and surgery; no medicine is currently licensed in the UK specifically for gynaecomastia.

The NHS recognises several evidence-based approaches to managing gynaecomastia, and the appropriate treatment depends on the underlying cause, duration, and severity of the condition.

Watchful waiting is often the first approach, particularly in adolescent males where spontaneous resolution is common. In cases where an underlying medical condition or medication is identified as the cause, addressing that root cause — such as adjusting a medication under medical supervision — may lead to improvement.

Weight management is relevant where pseudogynaecomastia (fatty tissue enlargement) is a contributing factor, and simple analgesia may be appropriate for breast pain or tenderness.

For persistent or significant gynaecomastia, the following options may be considered:

• Pharmacological treatment: It is important to note that no medicines are currently licensed in the UK specifically for the treatment of gynaecomastia. Medicines such as tamoxifen (a selective oestrogen receptor modulator) may be used off-label in some cases, typically initiated by a specialist. Evidence suggests benefit is greatest when treatment is started early in the course of the condition (generally within the first six to twelve months), before fibrous tissue replaces glandular tissue. Aromatase inhibitors have been used in some cases but have weaker supporting evidence and carry a risk of adverse effects; their use is less well established. Any pharmacological treatment should be discussed with and supervised by a specialist. Suspected adverse drug reactions should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

• Surgical intervention: Reduction mammoplasty or liposuction may be offered for longstanding or psychologically distressing gynaecomastia. NHS funding for surgery is subject to local Integrated Care Board (ICB) policies and is generally reserved for cases causing significant functional or psychological impact.

• Psychological support: Given the potential impact on body image and mental health, referral to psychological services may be appropriate in some cases.

NICE does not currently have a dedicated standalone guideline for gynaecomastia, but management is guided by NICE CKS, endocrinology, and surgical best practice. Patients are encouraged to discuss all options with their GP or a specialist rather than pursuing unproven alternatives.

Further information: NICE CKS — Gynaecomastia; NHS — Enlarged breasts in men (gynaecomastia); MHRA/EMC SmPCs for tamoxifen and anastrozole.

When to See a GP About Breast Tissue Changes

Any new or unexplained male breast change should be assessed by a GP promptly, as red-flag features — including a hard lump, nipple discharge, or skin changes — may warrant urgent referral via the two-week wait pathway.

Any new or unexplained change in breast tissue in a male should be assessed by a GP. While gynaecomastia is most commonly benign, it is important to exclude other causes, including male breast cancer, which — although rare — accounts for approximately 1% of all breast cancer diagnoses in the UK.

You should seek a GP appointment promptly if you notice:

• A firm or hard lump in one or both breasts, particularly if it is not centrally located beneath the nipple

• Nipple discharge, especially if it is bloodstained

• Skin changes over the breast, such as dimpling, puckering, or redness

• Rapid or asymmetric growth of breast tissue

• Pain or tenderness that is new, worsening, or unexplained

• Associated symptoms such as unexplained weight loss, fatigue, or testicular changes

A GP will typically take a thorough history, including a full medication review, and will perform a clinical examination that includes assessment of the testes. Blood tests may be arranged to assess hormone levels (including testosterone, oestradiol, LH, FSH, and prolactin), liver and kidney function, thyroid function, and — where a tumour is suspected — tumour markers such as β-hCG and AFP.

Where there are suspicious or red-flag features, the GP may refer urgently to a breast clinic via the suspected cancer (two-week wait) pathway, in line with NICE guideline NG12 (Suspected cancer: recognition and referral). Suspicious presentations are typically assessed through triple assessment at a symptomatic breast clinic, which may include clinical examination, imaging (mammography or ultrasound), and tissue sampling. Testicular ultrasound may also be arranged where a testicular cause is suspected.

Early assessment is particularly important if breast changes develop in adulthood without an obvious cause, as this may indicate an underlying endocrine or systemic condition requiring specific treatment. Do not delay seeking medical advice in favour of self-managed complementary approaches.

Further information: NICE NG12 — Suspected cancer: recognition and referral; NICE CKS — Gynaecomastia; NHS — Breast cancer in men.

Complementary Approaches: Safety Considerations and Realistic Expectations

Acupressure is generally low-risk but is not an effective treatment for gynaecomastia; it should only be used alongside — never instead of — conventional medical assessment and care.

For individuals who wish to explore complementary therapies alongside conventional care, it is important to approach this with realistic expectations and an awareness of safety considerations. Acupressure is generally considered low-risk when performed correctly, as it is non-invasive and does not involve needles or medications. However, this does not mean it is an effective treatment for gynaecomastia.

If you choose to explore acupressure or other complementary therapies, consider the following guidance:

• Always inform your GP that you are using complementary therapies, particularly if you are also taking medications or undergoing investigations.

• Choose qualified practitioners who are registered with a recognised professional body, such as the British Acupuncture Council (for acupuncture) or the Complementary and Natural Healthcare Council (CNHC).

• Be cautious of unsubstantiated claims: Any practitioner or online source claiming that acupressure can definitively treat or reverse gynaecomastia is making a claim unsupported by clinical evidence.

• Avoid unregulated supplements: Products marketed for 'male breast reduction' or hormonal balance are not regulated as medicines in the UK and may contain ingredients with unknown or harmful hormonal effects. Discuss any supplement use with your GP or pharmacist before starting.

• Observe safety precautions: Do not apply acupressure over undiagnosed lumps, broken or infected skin, or areas of recent surgery. Those with bleeding disorders or taking anticoagulants should seek medical advice first. Stop if pain, bruising, or worsening symptoms occur.

• Do not delay conventional assessment: Using complementary therapies while awaiting or alongside medical evaluation is a personal choice, but they should never replace a proper clinical diagnosis.

Lifestyle factors that support general hormonal health — such as maintaining a healthy weight, reducing alcohol intake, avoiding anabolic steroids, and managing stress — are broadly beneficial and align with NHS health promotion advice. These measures, while not a cure for gynaecomastia, may support overall wellbeing and complement any medical treatment plan. A balanced, informed approach that prioritises evidence-based care remains the most prudent course of action.

Further information: NHS — Complementary and alternative medicine.

Frequently Asked Questions